ACN
Accenture plc
ACN has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ACN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ACN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ACN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $250 | — |
| Current | 18x | $250 | — |
| Cheap | 21x | $285 | +14% |
| Fair | 28x | $381 | +52% |
| Expensive | 33x | $447 | +79% |
Historical ranges are pointers, not guarantees.
ACN's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
ACN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for ACN, with profitability holding steady.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ACN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.67 | +8.2% |
| Q3 2026 | $13.56 | +12% |
| Q2 2026 | $12.52 | -0.3% |
| Q1 2026 | $12.21 | +0.8% |
| Q4 2025 | $12.10 | +1.5% |
| Q3 2025 | $12.15 | +6.3% |
| Q2 2025 | $12.56 | +15% |
| Q1 2025 | $12.11 | +9.8% |
| Q4 2024 | $11.92 | +10% |
ACN has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
ACN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +6.2% |
| Q2 2026 | $18.7B | +5.6% |
| Q1 2026 | $18B | +8.3% |
| Q4 2025 | $18.7B | +6% |
| Q3 2025 | $17.6B | +7.3% |
| Q2 2025 | $17.7B | +7.7% |
| Q1 2025 | $16.7B | +5.4% |
| Q4 2024 | $17.7B | +9% |
ACN's revenue has grown year over year for nine quarters in a row: $18.7B last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.7 points |
| Q2 2026 | 17% | +0.1 points |
| Q1 2026 | 14% | +0.3 points |
| Q4 2025 | 15% | -1.3 points |
| Q3 2025 | 12% | -2.7 points |
| Q2 2025 | 17% | +0.8 points |
| Q1 2025 | 13% | +0.5 points |
| Q4 2024 | 17% | +0.9 points |
ACN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
ACN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8B | -25% |
| Q2 2026 | $3.6B | +2.4% |
| Q1 2026 | $3.7B | +37% |
| Q4 2025 | $1.5B | +73% |
| Q3 2025 | $3.8B | +20% |
| Q2 2025 | $3.5B | +16% |
| Q1 2025 | $2.7B | +35% |
| Q4 2024 | $870.3M | +103% |
ACN has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
ACN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -10.3M shares |
| 1 year | -3.8% | -24.1M shares |
| 3 years | -5.3% | -34M shares |
| 5 years | -6.2% | -40M shares |
| Available history | -6.8% | -44.1M shares |
ACN has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.3B |
| Q2 2026 | $1.2B |
| Q1 2026 | $1.7B |
| Q4 2025 | $2.3B |
| Q3 2025 | $473.9M |
| Q2 2025 | $1.8B |
| Q1 2025 | $1.4B |
| Q4 2024 | $898.3M |
ACN spent $7.5B buying back its own shares over the past year, up 63% from the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
ACN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
ACN has more cash than debt.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 88.9 | Overbought |
ACN's weekly RSI is 68 (neutral) and its Stochastic is 89 (overbought).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
ACN PE vs Technology Sector
| Metric | ACN | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 34% below |
| PE % | 10 | 35 | 25 pts below |
ACN is trading at 18x earnings, a 34% discount to the Technology sector's median of 28x.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
ACN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.0 | 9.2% above |
| 20 week MA | $192.0 | 30% above |
| 50 week MA | $204.9 | 22% above |
| 100 week MA | $250.4 | 0.2% below |
| 200 week MA | $285.4 | 12% below |
ACN has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
ACN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $212.2 | $257.3 | +21% |
| 2021 | $257.3 | $403.3 | +57% |
| 2022 | $403.3 | $266.1 | -34% |
| 2023 | $266.1 | $350.9 | +32% |
| 2024 | $350.9 | $356.2 | +1.5% |
| 2025 | $356.2 | $271.1 | -24% |
| 2026 YTD | $271.1 | $250.0 | -7.8% |
ACN has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.